← Open Payments lookup

MAKENZIE GRIFFIN: Open Payments

NPI 1093209645 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$406 in 22 payments from 15 companies in 2025. Trend: 2023 $965 · 2024 $1,267 · 2025 $406

Food & beverage: $406
CompanyPaymentsAmount
ABBVIE INC.3$52
Novo Nordisk Inc3$49
Astellas Pharma US Inc2$47
Aimmune Therapeutics, Inc.2$35
Lilly USA, LLC2$34
Xeris Pharmaceuticals, Inc.1$24
Abbott Laboratories1$22
Daiichi Sankyo Inc.1$22
GlaxoSmithKline, LLC.1$20
Bayer Healthcare Pharmaceuticals Inc.1$19

Products named: Veozah, ZENPEP, VRAYLAR, GVOKE HYPOPEN, UBRELVY, PROCLAIM, INJECTAFER, KISUNLA.

Industry payments across MD — which companies pay providers there.